AU6455896A - Novel factor viii:c polypeptide analogs with altered metal-binding properties - Google Patents
Novel factor viii:c polypeptide analogs with altered metal-binding propertiesInfo
- Publication number
- AU6455896A AU6455896A AU64558/96A AU6455896A AU6455896A AU 6455896 A AU6455896 A AU 6455896A AU 64558/96 A AU64558/96 A AU 64558/96A AU 6455896 A AU6455896 A AU 6455896A AU 6455896 A AU6455896 A AU 6455896A
- Authority
- AU
- Australia
- Prior art keywords
- factor viii
- binding properties
- polypeptide analogs
- novel factor
- altered metal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87195P | 1995-07-11 | 1995-07-11 | |
US000871 | 1995-07-11 | ||
PCT/US1996/011438 WO1997003193A1 (en) | 1995-07-11 | 1996-07-09 | Novel factor viii:c polypeptide analogs with altered metal-binding properties |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6455896A true AU6455896A (en) | 1997-02-10 |
Family
ID=21693379
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU64558/96A Abandoned AU6455896A (en) | 1995-07-11 | 1996-07-09 | Novel factor viii:c polypeptide analogs with altered metal-binding properties |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU6455896A (en) |
WO (1) | WO1997003193A1 (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5859204A (en) * | 1992-04-07 | 1999-01-12 | Emory University | Modified factor VIII |
US6180371B1 (en) | 1996-06-26 | 2001-01-30 | Emory University | Modified factor VIII |
US7560107B2 (en) | 1996-06-26 | 2009-07-14 | Emory University | Modified factor VIII |
US6458563B1 (en) | 1996-06-26 | 2002-10-01 | Emory University | Modified factor VIII |
EP1141313A2 (en) | 1998-12-31 | 2001-10-10 | Chiron Corporation | Improved expression of hiv polypeptides and production of virus-like particles |
PL1750733T3 (en) | 2004-05-03 | 2014-05-30 | Univ Emory | METHOD OF ADMINISTERING PORCINE B-DOMAINLESS fVIII |
EP1598367A1 (en) * | 2004-05-18 | 2005-11-23 | ZLB Behring GmbH | Modified coagulation factors with enhanced stability and their derivatives |
EP1816201A1 (en) | 2006-02-06 | 2007-08-08 | CSL Behring GmbH | Modified coagulation factor VIIa with extended half-life |
WO2008077616A1 (en) | 2006-12-22 | 2008-07-03 | Csl Behring Gmbh | Modified coagulation factors with prolonged in vivo half-life |
KR101648734B1 (en) | 2008-06-24 | 2016-08-18 | 체에스엘 베링 게엠베하 | Factor VIII, von Willebrand factor or complexes thereof with prolonged in vivo half-life |
EP2635297B1 (en) | 2010-11-05 | 2019-02-27 | Baxalta GmbH | A new variant of antihemophilic factor viii having increased specific activity |
EP2814502B1 (en) | 2012-02-15 | 2017-09-13 | CSL Behring GmbH | Von willebrand factor variants having improved factor viii binding affinity |
EP2796145B1 (en) | 2013-04-22 | 2017-11-01 | CSL Ltd. | A covalent complex of von willebrand factor and faktor viii linked by a disulphide bridge |
DK3164150T3 (en) | 2014-07-02 | 2021-02-08 | CSL Behring Lengnau AG | MODIFIED BY WILLEBRAND FACTOR |
US11155601B2 (en) | 2015-03-06 | 2021-10-26 | CSL Behring Lengnau AG | Modified von Willebrand factor having improved half-life |
JP6573989B2 (en) | 2015-05-22 | 2019-09-11 | ツェー・エス・エル・ベーリング・レングナウ・アクチエンゲゼルシャフト | A truncated von Willebrand factor polypeptide for the treatment of hemophilia |
EP3298036B1 (en) | 2015-05-22 | 2022-04-06 | CSL Behring Lengnau AG | Methods for preparing modified von willebrand factor |
SG11201805497QA (en) | 2016-01-07 | 2018-07-30 | Csl Behring Recombinant Facility Ag | Mutated truncated von willebrand factor |
SG10201912857XA (en) | 2016-01-07 | 2020-02-27 | CSL Behring Lengnau AG | Mutated von willebrand factor |
DK3538133T3 (en) | 2016-11-11 | 2021-04-19 | CSL Behring Lengnau AG | TRUNKED VON WILLEBRAND FACTOR POLYPEPTIDES FOR THE TREATMENT OF HEMOPHILIA |
JP2020504082A (en) | 2016-11-11 | 2020-02-06 | ツェー・エス・エル・ベーリング・レングナウ・アクチエンゲゼルシャフト | Truncated von Willebrand factor polypeptide for extravascular administration in the treatment or prevention of blood clotting disorders |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE465222C5 (en) * | 1989-12-15 | 1998-02-10 | Pharmacia & Upjohn Ab | A recombinant human factor VIII derivative and process for its preparation |
-
1996
- 1996-07-09 AU AU64558/96A patent/AU6455896A/en not_active Abandoned
- 1996-07-09 WO PCT/US1996/011438 patent/WO1997003193A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1997003193A1 (en) | 1997-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6455896A (en) | Novel factor viii:c polypeptide analogs with altered metal-binding properties | |
AU7203496A (en) | Novel peptides | |
AU5801296A (en) | Crosslinkable polypeptide compositions | |
AU6486196A (en) | Novel factor viii:c polypeptide analogs with altered protease sites | |
AU7043394A (en) | Association peptides | |
AU6255096A (en) | Pegylated modified proteins | |
AU1398792A (en) | Hybrid polypeptide | |
AU4427296A (en) | Novel peptide | |
AU4394396A (en) | Modified peptides | |
AU3977589A (en) | Novel peptides | |
AU2131195A (en) | Prophenins - antibiotic peptides | |
AU5166296A (en) | New peptides with immunomodulatory effects | |
AU4271793A (en) | Novel polypeptide | |
AU6291896A (en) | Novel factor viii:c polypeptide analogs comprising factor v domains or subdomains | |
AU8140094A (en) | New factor viii polypeptides | |
AU5284296A (en) | Immune-evading proteins | |
AU6890696A (en) | Peptide derivatives | |
AU6421298A (en) | Novel synthetic polypeptide | |
AU628500B2 (en) | Neurotrophic peptides | |
AU3734693A (en) | Neurotrophic peptides | |
AU4125193A (en) | Linear peptides | |
AUPM489194A0 (en) | Peptides | |
AU6890596A (en) | Peptide derivatives | |
AU6456096A (en) | Lysine 1689 factor viii:c polypeptide analogs | |
AU5161296A (en) | Anti-haemorrhagic peptides |